In conclusion, VEGF‐α plays a multifaceted role in cerebral ischaemia–reperfusion diseases, including the promotion of angiogenesis and neuroprotection, suggesting that VEGF‐α may be a potential therapeutic target for ischaemic brain diseases. Here, VEGFA is linked to brain ischemia.